Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1983 2
1987 2
1988 1
1989 3
1991 5
1994 1
1998 1
1999 3
2000 1
2001 4
2002 2
2003 1
2004 1
2006 1
2007 2
2010 1
2011 1
2012 3
2013 1
2016 3
2017 1
2018 2
2019 2
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
New therapeutic indications for botulinum toxins.
Cordivari C, Misra VP, Catania S, Lees AJ. Cordivari C, et al. Among authors: misra vp. Mov Disord. 2004 Mar;19 Suppl 8:S157-61. doi: 10.1002/mds.20071. Mov Disord. 2004. PMID: 15027069 Review.
Spectrum of practice in the routine management of cervical dystonia with abobotulinumtoxinA: findings from three prospective open-label observational studies.
Misra VP, Trosch RM, Maisonobe P, Om S. Misra VP, et al. J Clin Mov Disord. 2018 Jul 9;5:4. doi: 10.1186/s40734-018-0072-8. eCollection 2018. J Clin Mov Disord. 2018. PMID: 30002865 Free PMC article.
How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study.
Colosimo C, Charles D, Misra VP, Maisonobe P, Om S; INTEREST IN CD2 study group. Colosimo C, et al. Among authors: misra vp. J Neurol. 2019 Dec;266(12):3038-3046. doi: 10.1007/s00415-019-09527-2. Epub 2019 Sep 9. J Neurol. 2019. PMID: 31501975 Free PMC article.
What is primary lateral sclerosis?
Swash M, Desai J, Misra VP. Swash M, et al. Among authors: misra vp. J Neurol Sci. 1999 Nov 15;170(1):5-10. doi: 10.1016/s0022-510x(99)00184-7. J Neurol Sci. 1999. PMID: 10540029 Review.
Poster 498 Geographic Differences in the Characteristics of Cervical Dystonia Patients.
Trosch R, Misra VP, Om S, Maisonobe P. Trosch R, et al. Among authors: misra vp. PM R. 2016 Sep;8(9S):S322. doi: 10.1016/j.pmrj.2016.07.415. Epub 2016 Sep 24. PM R. 2016. PMID: 27673242 No abstract available.
INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin.
Misra VP, Colosimo C, Charles D, Chung TM, Maisonobe P, Om S; INTEREST IN CD2 study group. Misra VP, et al. J Neurol. 2018 Feb;265(2):402-409. doi: 10.1007/s00415-017-8698-2. Epub 2017 Dec 21. J Neurol. 2018. PMID: 29270685 Free PMC article.
Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study.
Colosimo C, Charles D, Misra VP, Maisonobe P, Om S; INTEREST IN CD2 study group. Colosimo C, et al. Among authors: misra vp. J Neurol. 2019 Dec;266(12):3047. doi: 10.1007/s00415-019-09549-w. J Neurol. 2019. PMID: 31595379 Free PMC article.
Poster 187 Is There a Correlation Between Tremor and Other Symptoms of Cervical Dystonia? An Analysis of Data from the Ongoing INTEREST IN CD2 Study.
Colosimo C, Misra VP, Charles D, Chung TM, Om S, Maisonobe P. Colosimo C, et al. Among authors: misra vp. PM R. 2016 Sep;8(9S):S222. doi: 10.1016/j.pmrj.2016.07.226. Epub 2016 Sep 24. PM R. 2016. PMID: 27672951 No abstract available.
Economic evaluation of AbobotulinumtoxinA vs OnabotulinumtoxinA in real-life clinical management of cervical dystonia.
Misra VP, Danchenko N, Maisonobe P, Lundkvist J, Hunger M. Misra VP, et al. J Clin Mov Disord. 2020 Feb 11;7:2. doi: 10.1186/s40734-020-0083-0. eCollection 2020. J Clin Mov Disord. 2020. PMID: 32071728 Free PMC article.
EMG-EMG coherence in writer's cramp.
Cordivari C, Lees AJ, Misra VP, Brown P. Cordivari C, et al. Among authors: misra vp. Mov Disord. 2002 Sep;17(5):1011-6. doi: 10.1002/mds.10212. Mov Disord. 2002. PMID: 12360551
47 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback